Free Shipping on orders over US$39.99 How to make these links

US Market Trends For Computer-Assisted Robotics-Assisted Surgery

By Devon Philpott and Kamran Zamanian, iData Research

Robot In Operating Room GettyImages-1215416571

In the medical industry, the adoption of new cutting edge technology is slow compared to other industries, such as the automotive industry.1 Computer-assisted and robotic-assisted surgery (CAS and RAS, respectively) have existed for decades, although a small percentage of the procedures performed take advantage of the new solutions available on the market today. In the coming years, the number of procedures using robotics and surgical navigation is predicted to increase at a double-digit rate each year to reach more than 6 million procedures by 2028.2 This increase in CAS and RAS can be attributed to the predicted increase in the use of navigation systems and robotic devices as many companies launch new or next-generation systems for assisted operation.

Figure 1: Number of procedures using navigation systems and robotics in the United States from 2018-2028. Access iData’s US robotics and surgical navigation market report to view more granular data.

Reasons For Slow CAS And RAS Adoption

Some argue that the use of CAS and RAS is not worth the time and money investment, because the use of this technology often increases the time to plan the procedure and reduces the number of procedures that can be completed in a given facility. that time frame.3 However, several studies have emerged in recent years highlighting the clinical benefits of using CAS or RAS compared to unassisted operations. For example, it has been found that the use of navigation for total hip arthroplasty (THA) procedures significantly reduces hip dislocations and the need for future revision surgeries compared to non-guided ones. operation.4,5 Other studies have shown that the use of RAS can significantly reduce recovery times, allowing patients to spend less time post-operatively in the hospital.6,7 As more studies like this are published, the adoption of CAS and RAS is expected to increase.

The exception to these doubts are neurosurgery procedures; it is considered standard of care that neurosurgeons use a navigation system. Consequently, the neurosurgery navigation system market has the highest adoption rate and poses a challenge to companies trying to enter the market by offering state-of-the-art robotic systems. In addition to the slow adoption of new technology, robotic solutions tend to be more expensive than navigation devices, some of which have an average selling price (ASP) of over $1 million for a robot while navigation systems are probably a fraction of that. cost.2 However, some companies, such as Brainlab, have developed low-cost robotic solutions that are priced competitively with navigation systems on the market.

Figure 2: Comparison of the average selling price (ASP) for navigation systems and robots for method types with the same application. Access iData’s US robotics and surgical navigation market report to view more granular data.

Recent Developments In CAS And RAS

Since 2018, the FDA has made several approvals in the US robotics and surgical navigation market, including clearances for devices as well as updated software modules. Companies granted clearance for their navigation and robotics products include, but are not limited to, Auris Health, Brainlab, DePuy Synthes, Intuitive Surgical, Medtronic, Smith & Nephew, and Zimmer Biomet. These companies remain up-to-date with market trends as they all developed robots for procedures with the highest compound annual growth rate during the forecast period, according to the iData Research report.2 Brainlab, Medtronic, and Zimmer Biomet have developed robotic solutions for neurosurgery, while DePuy Synthes, Smith & Nephew, and Zimmer Biomet have developed new robots to perform orthopedic procedures.

The minimally invasive surgery (MIS) segment of the robotic-assisted surgery market is the largest, with approximately 85% of all robotic procedures performed by 2021 being minimally invasive.2 The robotic-assisted MIS segment is dominated by Intuitive Surgical; however, several companies have entered the market, seeking to compete with Intuitive’s da Vinci system. Auris Health and Medtronic have both released robotic solutions for MIS along with several other competitors looking to chip away at Intuitive Surgical’s share of the market. These product releases are expected to help drive robotic procedure volume as these companies are well established in the medical device industry.

Of all the guided orthopedic procedures, THA has the lowest adoption compared to total or partial knee arthroplasties.2 However, computer-assisted THA procedures are expected to increase at the fastest rate due to the development of fluoroscopy-based navigation systems. These systems have gained great popularity over the past decade or so, which in turn has led to an increase in THA procedures performed from a direct anterior approach.8 Although the majority of navigated orthopedic procedures performed in 2021 are knee procedures, those procedures are expected to show a slower growth rate during the forecast period.2

Current CAS And RAS Adoption

Another major factor affecting the rate of adoption of CAS and RAS is the type of procedure. For minimally invasive robotics, urological procedures have the highest robotic penetration while cardiac procedures have the lowest adoption rate.2 While there is a small margin of error for all operations, there is greater caution taken for procedures involving vital organs such as the heart, hence the low adoption rate. For spinal surgery, the adoption of CAS is almost seven times higher than that of RAS in 2021.2 Interestingly, the opposite is seen for orthopedic surgery, where the adoption of RAS is more than two times higher than CAS in 2021.2 The difference in trends seen for orthopedic and spinal surgeries is likely due to the many new robotic orthopedic systems released recently, such as DePuy Synthes’ VELYS Robotic-Assisted Solution.

Figure 3: Adoption rates for robotic-assisted and computer assisted surgery in the US in 2021. Contact iData Research for more granular data.


There is no doubt that as technology advances around the world, more operations will be carried out using the latest technological advances. With the release of long-term impact studies, new product launches, and training programs, many patients and surgeons feel comfortable opting for a computer-assisted or robotic- assisted procedure in an unguided procedure for their operation. The increase in the number of procedures is accompanied by the increase in operating costs, which is driving the overall robotics and surgical navigation market in the United States.


  1. Shaw B, Chisholm O. Creeping in the Backdoor: Disruption in Medicine and Health. Front Pharmacol. 2020;11:818. doi:10.3389/fphar.2020.00818
  2. iData Research Inc. US Surgical Robotics and Navigation Market – 2022. Published June 17, 2022. Accessed June 17, 2022. [URL].
  3. Bakalar N. Are robotic surgeries better? The New York Times. Published August 16, 2021. Accessed May 13, 2022.
  4. Agarwal S, Eckhard L, Walter WL, et al. The use of computer navigation in total hip arthroplasty is associated with a reduced revision rate for dislocation: a study of 6,912 navigated THA procedures from the Australian Orthopedic Association National Joint Replacement Registry. Journal of Bone and Joint Surgery. 2021;103(20):1900-1905. doi:10.2106/JBJS.20.00950
  5. Sharma AK, Cizmic Z, Carroll KM, et al. Computer navigation for revision total hip arthroplasty reduces dislocation. TREES. Published online February 24, 2022. doi:10.1007/s43465-022-00606-7
  6. The da Vinci robot is used for minimally invasive surgery. Accessed May 13, 2022.
  7. Ali M, Kamson A, Yoo C, Singh I, Ferguson C, Dahl R. Early superior clinical outcome of robotic-assisted TKA versus conventional TKA in the same patient: a comparative analysis. J Knee Surg. Published online February 18, 2022. doi:10.1055/s-0042-1743232
  8. Werner JA, Schwarz J, Werner LA. The evolution of anterior total hip arthroplasty: the past, present, and future. Bulletin of the NYU Hospital for Joint Diseases. 2021;79(1):51-58. Accessed on May 13, 2022.

About the Authors:

Devon Philpott is a research analyst at iData Research. He has created and composed syndicated research projects about the medical device industry, publishing the US Robotics and Surgical Navigation report series.

Kamran Zamanian, Ph.D., is the CEO and founding partner of iData Research. He has spent more than 25 years working in the market research industry with a dedication to the study of medical devices used in the health of patients around the world.

About iData Research

For 17 years, iData Research has been a strong advocate for data-driven decision-making within the global medical device, dental, and pharmaceutical industries. By providing custom research and consulting solutions, iData empowers its clients to rely on source data and make key strategic decisions with confidence.

Source link

We will be happy to hear your thoughts

Leave a reply

Info Bbea
Enable registration in settings - general
Compare items
  • Total (0)
Shopping cart